Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/VALIANTLAB stock hub

NSE/VALIANTLAB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/VALIANTLABis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.3B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/VALIANTLAB

In the news

Latest news · NSE/VALIANTLAB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/En/a

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC-3.7

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/VALIANTLAB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

146

Groups with data

Currency

INR

Showing 146 of 146 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	79
Employees Change	2%
Employees Change Percent	2.6
Enterprise value	INR 4.2B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE0JWS01017
Last refreshed	2026-05-10
Market cap	INR 4.3B
Price	INR 79.15
Price currency	INR
Rev Per Employee	25,730,556.96x
Sector	Healthcare
Sic	2834
Symbol	nse/VALIANTLAB
Website	https://valiantlabs.in

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.01%
EV Earnings	-97.09x
EV/EBIT	235.5x
EV/EBITDA	105.83x
EV/Sales	2.07x
P/B ratio	1.35x
P/S ratio	2.11x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	0.88%
EBITDA Margin	1.86%
Gross margin	14.55%
Gross Profit	INR 295.7M
Gross Profit Growth	424.44%
Gross Profit Growth Q	15.04%
Gross Profit Growth3 Y	-20.75%
Net Income	INR -43.3M
Net Income Growth Years	0%
Pretax Margin	0.33%
Profit Margin	-2.13%
Profit Per Employee	INR -548,266
ROIC	-3.72

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-13.63%
EPS Growth Years	0
Revenue Growth	91.43x
Revenue Growth Q	48.9x
Revenue Growth Quarters	4x
Revenue Growth Years	0x
Revenue Growth3 Y	-13.34x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 629.1M
Debt	INR 537.7M
Debt EBITDA	INR 13.53
Debt Equity	INR 0.17
Equity	INR 3.2B
Interest Coverage	1.89
Net Cash	INR 91.4M
Net Cash By Market Cap	INR 2.13
Net Cash Growth	169.16%
Net Debt EBITDA	INR -2.42
Net Debt Equity	INR -0.03
Tangible Book Value	INR 3.2B
Tangible Book Value Per Share	INR 63.42
WACC	7.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-24.8%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-13.63%
200-day SMA	74
50-day SMA	62.26
50-day SMA vs 200-day SMA	50under200
All Time High	215
All Time High Change	-63.18%
All Time High Date	2024-02-02
All Time Low	49.51
All Time Low Change	59.87%
All Time Low Date	2026-03-04
ATR	4.19
Beta	0.96
Beta1y	0.8
Beta2y	0.53
Ch YTD	13.07
High	81
High52	124.4
High52 Date	2025-06-12
High52ch	-36.37%
Low	78
Low52	49.51
Low52 Date	2026-03-04
Low52ch	59.87%
Ma50ch	27.12%
Price vs 200-day SMA	6.96%
RSI	66.82
RSI Monthly	39.31
RSI Weekly	58.64
Sharpe ratio	-0.18x
Sortino ratio	-0.16
Total Return	-24.8%
Tr YTD	13.07
Tr1m	33.77%
Tr1w	3.48%
Tr3m	34.47%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 17.9M
Operating Income Growth3 Y	-65.5
Operating margin	0.88

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12,146,517%
Shares Insiders	29.86%
Shares Institutions	1.01%
Shares Out	54,312,500
Shares Qo Q	8.5%
Shares Yo Y	24.8%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	80,605.5x
Bv Per Share	63.44
Ch1m	33.77
Ch1w	3.48
Ch1y	-19.83
Ch3m	34.47
Ch6m	-5.79
Change	-0.99%
Change From Open	-0.94
Close	79.94
Days Gap	-0.05
Depreciation Amortization	19,974,000
Dollar Volume	772,266.6
Earnings Date	2026-05-30
EBIT	INR 17.9M
EBITDA	INR 37.8M
EPS	INR -0.84
F Score	1
Fiscal Year End	March
Founded	1,980
Income Tax	INR 50.1M
Is Primary Listing	1
Last Earnings Date	2026-02-11
Last Report Date	2025-12-31
Ma150	68.6
Ma150ch	15.38%
Ma20	71.69
Ma20ch	10.4%
Next Earnings Date	2026-05-30
Open	79.9
Position In Range	38.33
Price Date	2026-05-08
Price EBITDA	INR 114
Ptbv Ratio	1.35
Relative Volume	0.12x
Revenue	2,032,714,000x
Tax By Revenue	2.46x
Tax Rate	742.15%
Tr6m	-5.79%
Volume	9,757

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/VALIANTLAB pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/VALIANTLAB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/VALIANTLAB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.0%

Share of float held by funds and institutions

Insider ownership

+29.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+24.8%

Negative means the company is buying back shares.

Technical

NSE/VALIANTLAB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

66.8

Neutral momentum band

Price vs 200-day MA

+7.0%

50/200-day relationship not available

Beta (5Y)

0.96

Moves roughly with the market

Sharpe ratio

-0.18

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/VALIANTLAB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/VALIANTLAB stock rating?

nse/VALIANTLAB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/VALIANTLAB analysis?

The full report lives at /stocks/nse/VALIANTLAB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/VALIANTLAB?

The latest report frames nse/VALIANTLAB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/VALIANTLAB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.